Il tuo browser è obsoleto
Con un browser aggiornato, l'esperienza di navigazione sul sito Web di Medtronic sarà migliore. Aggiorna il mio browser adesso.
Si, sono un operatore sanitario
Note: Ai sensi e per gli effetti dell’Art. 76 D.P.R. 445/2000 consapevole della responsabilità e delle conseguenze civili e penali previste in caso di dichiarazioni mendaci e/o formazione od uso di atti falsi, nonché in caso di esibizione atti contenenti dati non più corrispondenti a verità e consapevole altresì che qualora emerga la non veridicità del contenuto della presente decadranno i benefici per i quali la stessa è rilasciata confermo di essere un OPERATORE SANITARIO.
I contenuti presenti in questo sito contengono informazioni rivolte agli operatori sanitari, in quanto si riferiscono a prodotti rientranti nella categoria dei dispositivi medici che richiedono l’impiego o l’intervento da parte di professionisti del settore medico-sanitario.
Around 70 million Americans have sleep disorders, such as obstructive sleep apnea and snoring.1,2 Studies link sleep deficiency to multiple comorbidities in adults, including heart disease and stroke,1,3-5 as well as an increased risk of car crashes, work-related accidents, and diminished job performance.1,3-6 In children, obstructive sleep apnea can significantly affect behavior and learning ability.5-7 Yet most people with sleep disorders are undiagnosed.1,3 Medtronic offers numerous innovative solutions to help you treat your patients with sleep-disordered breathing.
The AIRvance™ Tongue and Hyoid Suspension System* may be used for two surgical treatments, each of which requires about 30 minutes to perform.
The objective of the AIRvance Tongue Suspension procedure is to advance and stabilize the genioglossus muscle. This prevents it from falling back and occluding the airway when the patient is supine and asleep, thus helping prevent obstructive sleep apnea and/or snoring. During the procedure, you implant a small titanium screw with attached sutures in the lower mandible, then loop the sutures through the tongue to form a hammock that suspends the tongue.
View an animated surgical video of tongue suspension (3:35, 21.7 MB) using our AIRvance System for obstructive sleep apnea.
The AIRvance Hyoid Suspension procedure is designed to help improve airway patency by providing anterior/posterior and lateral support of the lower airway, as well as lateral support of the tongue base. This is accomplished by advancing and suspending the hyoid bone and associated musculature to treat obstructive sleep apnea and/or snoring. During the procedure, you implant two small titanium screws with attached sutures in the lower mandible, and loop the sutures around the hyoid bone to suspend it.
View an animated surgical video of hyoid suspension (4:10, 25.0 MB) using our AIRvance System for obstructive sleep apnea.
If your patient's sleep disorder is caused by inferior turbinate deformity or hypertrophy, choose our patented Inferior Turbinate Blades and Straightshot® M4 Microdebrider for powered inferior turbinoplasty. These products can help you reduce inferior turbinate volume while preserving mucosa and avoiding unpredictable damage to surrounding tissue. Clinical studies demonstrate significantly better long-term results and a reduced risk of complications.8-12
View a surgical video of powered inferior turbinoplasty (2:35, 9.8 MB).
*As of August 2011 the Repose® brand was changed to AIRvance.
Brain Facts, A Primer on the Brain and Nervous System. Society for Neuroscience, 2008.
Cleveland Clinic. Health Information: Sleep Disorders. Accessed February 10, 2010.
National Heart, Lung, and Blood Institute. Diseases and Conditions – Sleep Apnea. Accessed February 10, 2010.
Sleep Apnea. Am Fam Phys 2005; 72(7):1319-20.
National Sleep Foundation: ABCs of ZZZZs. Accessed February 10, 2010.
National Heart, Lung, and Blood Institute. Sleep Disorders Information: Problem Sleepiness in Your Patient. Accessed February 10, 2010.
Chan J, Edman JC, Koltai PJ. Obstructive sleep apnea in children. Am Fam Phys 2004; 69(5):1147-54.
Liu C-M, Tan C-D, Lee F-P, Lin K-N, Huang H-M. Microdebrider-assisted versus radiofrequency-assisted inferior turbinoplasty. Laryngoscope 2009;119:414-8.
Berger G, Ophir D, Pitaro K, Landsberg R. Histopathological changes after Coblation® inferior turbinate reduction. Arch Otolaryngol Head Neck Surg 2008;134:819-23.
Lee JY, Lee JD. Comparative study on the long-term effectiveness between Coblation- and microdebrider-assisted partial turbinoplasty. Laryngoscope 2006;116:729-34.
Huang TW, Cheng P. Changes in nasal resistance and quality of life after endoscopic microdebrider-assisted inferior turbinoplasty in patients with perennial allergic rhinitis. Arch Otolaryngol Head Neck Surg 2006; 132: 990-993.
Sacks R, Thornton MA, Boustred RN. Modified endoscopic turbinoplasty — long-term results compared to submucosal electrocautery and submucosal powered turbinoplasty. Presented at: American Rhinologic Society Spring Meeting; May 13–16, 2005; Boca Raton, FL.
Medtronic Italia S.p.A. Società a socio unico soggetta ad attività di direzione e coordinamento da parte di Medtronic PLC.
Cap. soc. € 1.200.487,00 - Codice fiscale, partita IVA e numero di iscrizione al Registro delle Imprese di Milano-Monza-Brianza-Lodi 09238800156 – REA MI – 1275682. Sede Legale e Uffici Via Varesina, 162 Edificio Raimondi - 20156 Milano.